{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:08:54Z","timestamp":1747224534380,"version":"3.40.5"},"reference-count":9,"publisher":"PAGEPress Publications","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Reports"],"abstract":"<jats:p>Not available<\/jats:p>","DOI":"10.4081\/dr.2023.9763","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:42:02Z","timestamp":1692884522000},"source":"Crossref","is-referenced-by-count":0,"title":["COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports"],"prefix":"10.4081","author":[{"given":"Angelo Massimiliano","family":"D'Erme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9189-9204","authenticated-orcid":false,"given":"Cristian","family":"Fidanzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Dini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Bagnoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agata","family":"Janowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"key":"12439","doi-asserted-by":"crossref","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI\/GA\u00b2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria [published online ahead of print, 2021 Sep 18]. Allergy. 2021;10.1111\/all.15090. doi:10.1111\/all.15090","DOI":"10.1111\/all.15090"},{"key":"12440","doi-asserted-by":"crossref","unstructured":"Alizadeh Aghdam M, Knol EF, van den Elzen M, et al. Response of Fc\u03b5RI-bearing leucocytes to omalizumab in chronic spontaneous urticaria. Clin Exp Allergy. 2020;50(3):364-371. doi:10.1111\/cea.13566","DOI":"10.1111\/cea.13566"},{"key":"12441","doi-asserted-by":"crossref","unstructured":"Bostan E, Zaid F, Karaduman A, et al. The effect of COVID-19 on patients with chronic spontaneous urticaria treated with omalizumab and antihistamines: A cross-sectional, comparative study. J Cosmet Dermatol. 2021;20(11):3369-3375. doi:10.1111\/jocd.14484","DOI":"10.1111\/jocd.14484"},{"key":"12442","doi-asserted-by":"crossref","unstructured":"Winthrop KL, Mariette X, Silva JT, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobulins and complement factors). Clin Microbiol Infect. 2018;24 Suppl 2:S21-S40. doi:10.1016\/j.cmi.2018.02.002","DOI":"10.1016\/j.cmi.2018.02.002"},{"key":"12443","doi-asserted-by":"crossref","unstructured":"Passante M, Napolitano M, Dastoli S, et al. Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021;34(6):e15111. doi:10.1111\/dth.15111","DOI":"10.1111\/dth.15111"},{"key":"12444","doi-asserted-by":"crossref","unstructured":"Criado PR, Criado RFJ, Pincelli TP, Yoshimoto TA, Naufal GGA, Abdalla BMZ. Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab. Int J Dermatol. 2020;59(10):1294-1295. doi:10.1111\/ijd.15134","DOI":"10.1111\/ijd.15134"},{"key":"12445","doi-asserted-by":"crossref","unstructured":"Klimek L, Pfaar O, Worm M, et al. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of \u00c4rzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft f\u00fcr Allergologie und Klinische Immunologie (DGAKI)B, Gesellschaft f\u00fcr P\u00e4diatrische Allergologie und Umweltmedizin (GPA)C, \u00d6sterreichische Gesellschaft f\u00fcr Allergologie und Immunologie (\u00d6GAI)D, Luxemburgische Gesellschaft f\u00fcr Allergologie und Immunologie (LGAI)E, \u00d6sterreichische Gesellschaft f\u00fcr Pneumologie (\u00d6GP)F in co-operation with the German, Austrian, and Swiss ARIA groupsG, and the European Academy of Allergy and Clinical Immunology (EAACI)H. Allergol Select. 2020;4:53-68. Published 2020 Sep 7. doi:10.5414\/ALX02166E","DOI":"10.5414\/ALX02166E"},{"key":"12446","doi-asserted-by":"crossref","unstructured":"Abdelmaksoud A, Goldust M, Vestita M. Omalizumab and COVID-19 treatment: Could it help?. Dermatol Ther. 2020;33(4):e13792. doi:10.1111\/dth.13792","DOI":"10.1111\/dth.13792"},{"key":"12447","doi-asserted-by":"crossref","unstructured":"Kocat\u00fcrk E, Salman A, Cherrez-Ojeda I, et al. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy. 2021;76(3):816-830. doi:10.1111\/all.14687","DOI":"10.1111\/all.14687"}],"container-title":["Dermatology Reports"],"original-title":[],"link":[{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9763\/9183","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/download\/9763\/9183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:42:10Z","timestamp":1692884530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.pagepress.org\/journals\/index.php\/dr\/article\/view\/9763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":9,"URL":"https:\/\/doi.org\/10.4081\/dr.2023.9763","relation":{},"ISSN":["2036-7406","2036-7392"],"issn-type":[{"type":"electronic","value":"2036-7406"},{"type":"print","value":"2036-7392"}],"subject":[],"published":{"date-parts":[[2023,8,24]]}}}